William E. Fitzsimmons. (2022). COVID-19 vaccine associated transverse myelitis-Evusheld as an option when vaccination is not recommended due to severe adverse events. Taylor & Francis Group.
Chicago Style (17th ed.) CitationWilliam E. Fitzsimmons. COVID-19 Vaccine Associated Transverse Myelitis-Evusheld as an Option When Vaccination Is Not Recommended Due to Severe Adverse Events. Taylor & Francis Group, 2022.
MLA (9th ed.) CitationWilliam E. Fitzsimmons. COVID-19 Vaccine Associated Transverse Myelitis-Evusheld as an Option When Vaccination Is Not Recommended Due to Severe Adverse Events. Taylor & Francis Group, 2022.
Warning: These citations may not always be 100% accurate.